Details:

Corporate Authors:
Centers for Disease Control and Prevention (U.S.) ; National Center for Emerging Zoonotic and Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Antibiotic Resistance Coordination and Strategy Unit . ;
Centers for Disease Control and Prevention (U.S.) ; National Center for Emerging Zoonotic and Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Antibiotic Resistance Coordination and Strategy Unit . ; Less -
Description:
Type: Bacteria Also known as: Extended-spectrum β-lactamase About: ESBL-producing Enterobacteriaceae are a concern in healthcare settings and the community. They can spread rapidly and cause or complicate infections in healthy people. ESBL stands for extended-spectrum beta-lactamase. ESBLs are enzymes that break down commonly used antibiotics, such as penicillins and cephalosporins, making them ineffective. Estimated cases in hospitalized patients in 2017: 197,400 Estimated deaths in 2017: 9,100 This fact sheet is part of CDC’s 2019 Antibiotic Resistance Threats Report. The full report, including data sources, is available at www.cdc.gov/DrugResistance/Biggest-Threats.html. CS298822-A Publication date from document properties. esbl-508.pdf
Subject:
[+]
Anti-Bacterial Agents
Anti-Infective Agents
Antimicrobial Stewardship
Drug Resistance, Microbial
Enterobacteriaceae
Enterobacteriaceae Infections

Document Type:
Pamphlet (or booklet) ;
Genre:
Fact Sheet ;
Place as Subject:
United States ;
Collection(s):
Stephen B. Thacker CDC Library collection
Main Document Checksum:
[+]
urn:sha256:1b1b33a8062c6908d785e7758315696936e0d5bef3f94ede94c429d0ce954322
File Type:

Supporting Files

• 	ESBL.html	htm
  	Biggest-Threats.html	htm

More +